Bliss GVS Pharma Ltd
NSE:BLISSGVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bliss GVS Pharma Ltd
NSE:BLISSGVS
|
IN |
|
M
|
Minesto AB
DUS:7MN
|
SE |
|
Caliber Imaging & Diagnostics Inc
OTC:LCDX
|
US |
|
A
|
Australia and New Zealand Banking Group Ltd
F:ANB
|
AU |
|
B
|
BayWa AG
LSE:0AH7
|
DE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BLISSGVS's stock price target?
Not Available
BLISSGVS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Bliss GVS Pharma Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 6 years is 2%.
What is the Gross Profit forecast for Bliss GVS Pharma Ltd?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 6 years is -7%.
What is the Operating Income forecast for Bliss GVS Pharma Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 11 years is 1%.
What is the Pre-Tax Income forecast for Bliss GVS Pharma Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 6 years is 11%.
What is the Net Income forecast for Bliss GVS Pharma Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 6 years is 10%.
